0001209191-17-046037.txt : 20170721
0001209191-17-046037.hdr.sgml : 20170721
20170721214709
ACCESSION NUMBER: 0001209191-17-046037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170720
FILED AS OF DATE: 20170721
DATE AS OF CHANGE: 20170721
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ruff Shamim
CENTRAL INDEX KEY: 0001685986
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 17977450
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-274-4000
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 415
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-07-20
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001685986
Ruff Shamim
215 FIRST STREET
SUITE 415
CAMBRIDGE
MA
02142
0
1
0
0
SVP, Regulatory Affairs & Qual
Common Stock
2017-07-20
4
M
0
6250
13.71
A
27312
D
Common Stock
2017-07-20
4
S
0
6250
42.00
D
21062
D
Common Stock
2017-07-21
4
M
0
4388
13.90
A
25450
D
Common Stock
2017-07-21
4
S
0
4388
44.00
D
21062
D
Common Stock
2017-07-21
4
M
0
1500
14.76
A
22562
D
Common Stock
2017-07-21
4
S
0
1500
44.00
A
21062
D
Non-Qualified Stock Options (right to buy)
13.71
2017-07-20
4
M
0
6250
13.71
D
2017-02-28
2026-02-28
Common Stock
6250
17708
D
Non-Qualified Stock Options (right to buy)
13.90
2017-07-21
4
M
0
4388
13.90
D
2016-02-27
2025-02-27
Common Stock
4388
5098
D
Incentive Stock Option (right to buy)
14.76
2017-07-21
4
M
0
1500
14.76
D
2015-05-06
2025-05-06
Common Stock
1500
52644
D
This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on May 12, 2017, accordingly, the reporting person had no discretion with regards to the timing of the transaction.
/s/David Tyronne Howton, as Attorney-in-Fact for Shamim Ruff
2017-07-21